Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease

Molecular Nutrition and Food Research

Volumn 56, Issue 10, 2012, Pages 1541-1558

  Peng, Chiung Chi ^a   Hsieh, Chiu Lan ^b   Ker, Yaw Bee ^c   Wang, Hsi Yi ^b   Chen, Kuan Chou ^d,e   Peng, Robert Y ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Chronic kidney disease; Cytokines; Hyperlipidemia; Quercetin

Indexed keywords

BAD PROTEIN, RAT; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; CASPASE 3; CATECHIN; CHOLESTEROL; CREATININE; DOXORUBICIN; FLAVANONE DERIVATIVE; INSULIN; MALONALDEHYDE; NARINGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BAD; PROTEIN BAX; QUERCETIN; RUTOSIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; URIC ACID;

ALBUMINURIA; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; GLOMERULUS FILTRATION RATE; KIDNEY; MALE; METABOLISM; NICK END LABELING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URINE;

ALBUMINURIA; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOOD UREA NITROGEN; CASPASE 3; CATECHIN; CHOLESTEROL; CREATININE; DIETARY SUPPLEMENTS; DOXORUBICIN; FLAVANONES; GLOMERULAR FILTRATION RATE; IN SITU NICK-END LABELING; INSULIN; KIDNEY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PPAR ALPHA; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; RUTIN; SUPEROXIDE DISMUTASE; TRIGLYCERIDES; URIC ACID;

RATTUS;

EID: 84867054038     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200178     Document Type: Article

References (42)

1. Carrero, J. J., Yilmaz, M. I., Lindholm, B., Stenvinkel, P., Cytokine dysregulation in chronic kidney disease: how can we treat it? Blood Purif. 2008, 26, 291-299.
2. Curtis, B. M., Parfrey, P. S., Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. Cardiol. Clin. 2005, 23, 275-284.
3. Best, P. J., Reddan, D. N., Berger, P.B, Szczech, L. A. et al., Cardiovascular disease and chronic kidney disease: insights and an update. Am. Heart J. 2004, 148, 230-242.
4. Wang, Y., Wang, Y. P., Tay, Y. C., Harris, D. C., Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int. 2000, 58, 1797-1804.
5. Böttinger, E. P., Bitzer, M., TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 2002, 13, 2600-2610.
6. Parfrey, P. S., Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol. Dial Transplant. 2000, 15 Suppl 5, 58-68.
7. Bak, Y., Kim, H., Kang, J. W., Lee, D. H. et al., A synthetic naringenin derivative, 5-hydroxy-7, 4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells. J. Agric. Food Chem. 2011, 59, 10286-10297.
8. Renugadevi, J., Prabu, S. M., Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 2009, 256, 128-134.
9. Kamalakkannan, N., Stanely Mainzen Prince, P., The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. J. Pharm. Pharmacol. 2006, 58, 1091-1098.
10. Guardia, T., Rotelli, A. E., Juarez, A. O., Pelzer, L. E., Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001, 56, 683-687.
11. Kwon, K. H., Murakami, A., Tanaka, T., Ohigashi, H., Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 2005, 69, 395-406.
12. Karthick, M., Prince, P.S.M., Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats. J. Pharm. Pharmacol. 2006, 58, 701-707.
13. Hase, M., Babazono, T., Karibe, S., Kinae, N. et al., Renoprotective effects of tea catechin in streptozotocin- induced diabetic rats. Int. Urol. Nephrol. 2006, 38, 693-699.
14. Korish, A. A., Arafah, M. M., Catechin combined with vitamins C and E ameliorates insulin resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF). Arch. Gerontol. Geriatr. 2008, 46, 25-39.
15. Hsu, S. P., Wu, M. S., Yang, C. C., Huang, K. C. et al., Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am. J. Clin. Nutr. 2007, 86, 1539-1547.
16. Boots, A. W., Haenen, G. R., Bast, A., Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325-337.
17. Wilson, R. T., Wang, J., Chinchilli, V., Richie, J. P. et al., Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am. J. Epidemiol. 2009, 170, 717-729.
18. Egert, S., Bosy-Westphal, A., Seiberl, J., Kürbitz, C. et al., Quercetin reduces systolic blood pressure and plasma oxidized low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102, 1065-1074.
19. Hsieh, C. L., Peng, C. C., Cheng, Y. M., Lin, L. Y. et al., Quercetin and ferulic acid aggravate renal carcinoma in long-term diabetic victims. J. Agric. Food Chem. 2010, 58, 9273-9280.
20. National Kidney Foundation, 2002. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1-266.
21. Peng, C. C., Chen, K. C., Lu, H. Y., Peng, R. Y. Treadmill exercise improved adriamycin-induced nephropathy. J. Biol. Regul Homeost Agents 2012, 26, 15-28.
22. Stevens, L. A., Coresh, J., Greene, T., Levey, A. S., Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006, 354, 2473-2483.
23. Lu, N., Chen, P., Yang, Q., Peng Y. Y., Anti- and pro-oxidant effects of (+)-catechin on hemoglobin-induced protein oxidative damage. Toxicol. In Vitro. 2011, 25, 833-838.
24. Fouque, D., Pelletier, S., Mafra, D., Chauveau, P., Nutrition and chronic kidney disease. Kidney Int. 2011, 80, 348-357.
25. Shoji, T., Nishizawa, Y., Chronic kidney disease as a metabolic syndrome with malnutrition-need for strict control of risk factors. Intern. Med. 2005, 44, 179-187.
26. Kim, D. W., Hwang, I. K., Lim, S. S., Yoo, K. Y. et al., Germinated Buckwheat extract decreases blood pressure and nitrotyrosine immunoreactivity in aortic endothelial cells in spontaneously hypertensive rats. Phytother Res. 2009, 23, 993-998.
27. Redondo, A., Estrella, N., Lorenzo, A. G., Cruzado, M. et al., Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells fromhypertensive rats. Free Radic. Res. 2012, 5, 619-627.
28. Gábor, M., The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats. Arzneimittelforschung 1981, 31, 442-445.
29. Ahmed, N. Z., Anti-inflammatory effect of some natural flavonoids on the hepatic lysosomal enzymes in rats. N. Y. Sci. J. 2011, 4, 6-14.
30. Rao, M., Kumar, M. M., Rao, M. A., In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. J. Biochem. 1999, 125, 383-390.
31. Nikolic, J., Sokolovic, D., Lespeflan, a bioflavonoid, and amidinotransferase interaction in mercury chloride intoxication. Ren. Fail 2004, 26, 607-611.
32. Cos, P., Ying, L., Calomme, M., Hu, J. P. et al., Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 1998, 61, 71-76.
33. Shin, J. K., Kim, G. N., Jang, H. D., Antioxidant and pro-oxidant effects of green tea extracts in oxygen radical absorbance capacity assay. J. Med. Food 2007, 10, 32-40.
34. Olszanecka-Glinianowicz, M., Zahorska-Markiewicz, B., Janowska, J., The effect of weight loss on serum concentrations of nitric oxide, TNF-alpha and soluble TNF-alpha receptors. Endokrynol. Pol. 2006, 57, 487-493.
35. Fock, R. A., Vinolo, M. A., de Moura Sá Rocha, V., de Sá Rocha, L. C. et al., Protein-energy malnutrition decreases the expression of TLR-4/MD-2 and CD14 receptors in peritoneal macrophages and reduces the synthesis of TNF-alpha in response to lipopolysaccharide (LPS) in mice. Cytokine 2007, 40, 105-114.
36. Kyzer, S., Binyamini, J., Chaimoff, C., Fishman, P., The effect of surgically induced weight reduction on the serum levels of the cytokines: interleukin-3 and tumor necrosis factor. Obes. Surg. 1999, 9, 229-234.
37. Wang, Y., Qin, Z. H., Nakai, M., Chen, R. W. et al., Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-kappa B activation and apoptosis. Neuroscience 1999, 94, 1153-1162.
38. Berger, J., Moller, D. E., The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53, 409-435.
39. Issemann, I., Green, S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347, 645-650.
40. Cree, M. G., Newcomer, B. R., Herndon, D. N., Qian, T. et al., PPAR-α agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial. Nutr. Metab. 2007, 4, 1-10.
41. Mack, R., Skurnick, B., Sterling-Jean, Y., Pedra-Nobre, M. et al., Fasting insulin levels as a measure of insulin resistance in American blacks. J. Med. 2003, 34, 31-38.
42. Hotamisligil, G. S., Mechanisms of TNF-alpha-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes 1999, 107, 119-125.